Lysine Methyltransferases Signaling: Histones are Just the Tip of the Iceberg
- 23 September 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Protein & Peptide Science
- Vol. 21 (7), 655-674
- https://doi.org/10.2174/1871527319666200102101608
Abstract
Protein lysine methylation is a functionally diverse post-translational modification involved in various major cellular processes. Lysine methylation can modulate proteins activity, stability, localization and/or interaction, resulting in specific downstream signaling and biological outcomes. Lysine methylation is a dynamic and fine-tuned process, deregulation of which often leads to human pathologies. In particular, the lysine methylome and its associated signaling network can be linked to carcinogenesis and cancer progression. Histone modifications and chromatin regulation is a major aspect of lysine methylation importance, but increasing evidence suggests that a high relevance and impact of non-histone lysine methylation signaling has emerged in recent years. In this review, we draw an updated picture of the current scientific knowledge regarding non-histone lysine methylation signaling and its implication in physiological and pathological processes. We aim to demonstrate the significance of lysine methylation as a major and yet underestimated posttranslational modification, and to raise the importance of this modification in both epigenetic and cellular signaling by focusing on the observed activities of SET- and 7β-strand- containing human lysine methyltransferases. Recent evidence suggests that what has been observed so far regarding lysine methylation’s implication in human pathologies is only the tip of the iceberg. Therefore, the exploration of the “methylome network” raises the possibility to use these enzymes and their substrates as promising new therapeutic targets for the development of future epigenetic and methyllysine signaling cancer treatments.Keywords
Funding Information
- Fondation pour la Recherche Médicale (ECO20170637491)
- Ligue Contre le Cancer (ANR-AAP-CE11JCJC2016)
This publication has 136 references indexed in Scilit:
- Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase BNature Communications, 2012
- MPP8 mediates the interactions between DNA methyltransferase Dnmt3a and H3K9 methyltransferase GLP/G9aNature Communications, 2011
- A unique chromatin signature uncovers early developmental enhancers in humansNature, 2010
- Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signalingNature Immunology, 2010
- Regulation of NF-κB by NSD1/FBXL11-dependent reversible lysine methylation of p65Proceedings of the National Academy of Sciences, 2009
- Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cellsProceedings of the National Academy of Sciences, 2009
- Negative regulation of NF-κB action by Set9-mediated lysine methylation of the RelA subunitThe EMBO Journal, 2009
- Protein lysine methyltransferase G9a acts on non-histone targetsNature Chemical Biology, 2008
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- The language of covalent histone modificationsNature, 2000